EU Science Hub

Search

Commission launches a new tool to report cancer burden statistics and trends across Europe
Dec 14 2018

Scientists from the JRC and WHO's International Agency for Research on Cancer (IARC) released the latest 2018 estimates on the burden of cancer in Europe. Cancer incidence and mortality indicators have been computed for 40 European countries on 34 types of cancer as well as for all cancer sites combined. These estimates are the joint outcome of a collaborative exercise led by IARC, in collaboration with JRC, the European Network of Cancer Registries and the International Association of Cancer Registries.

Hydrophobicity of nanoparticles
Dec 14 2018

JRC scientists developed a quantitative method for measuring the surface energy and hydrophobicity of nanomaterials, as the knowledge about hydrophobicity is important when assessing potential risks of chemicals.

Hydrophobicity is an important parameter to determine for the risk assessment of chemicals and in particular of nanomaterials.

Why?

Because hydrophobicity plays a critical role in various biological processes such as:

JRC helps to coordinate more transparency in global matrix reference material production
Dec 06 2018

The JRC hosted a meeting among nine major publicly funded reference material (RM) producers at the JRC-Geel site in Belgium. The aim was to assist in the overall prioritisation of RM production internationally, to avoid duplication, to tackle replacement of running out materials and to identify future needs and trends.

Reference materials (RMs) and certified reference materials (CRMs) are important quality assurance tools for precise and comparable measurements.

A Tale of Two Toxicologies – new book on the history of alternative methods
A Tale of Two Toxicologies – new book on the history of alternative methods
Dec 11 2018

JRC scientists have contributed to the editing and writing of a book on the history of alternative methods in toxicology and chemical safety assessment.

The book presents historical perspectives on the development, validation, acceptance and use of alternatives to animal testing over the past half-century, with an emphasis on humanity and good science, in line with the Three Rs (Replacement, Reduction, Refinement of animal procedures).

FAD-2018-0002

Product: 
Pediococcus acidilactici DSM 13943, Lactobacillus plantarum DSM 8862 and Lactobacillus plantarum DSM 8866
Active Substance(s): 

Pediococcus acidilactici DSM 13943, Lactobacillus plantarum DSM 8862 and Lactobacillus planatarum DSM 8866

Date of Report: 
Friday, 9 November, 2018
Executive summary : 

FAD-2018-0013

Product: 
L-histidine monohydrochloride monohydrate produced by Corynebacterium glutamicum KCCM80172
Active Substance(s): 

L-histidine

Date of Report: 
Friday, 9 November, 2018
Executive summary : 

FAD-2010-0060

Product: 
Astaxanthin-rich Phaffia rhodozyma (ATTCC SD 5340)
Active Substance(s): 

Astaxanthin

Date of Report: 
Wednesday, 14 November, 2018
Executive summary : 

Pages

JRC wide hidden block